271 related articles for article (PubMed ID: 12393518)
1. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
2. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
Kim DD; Miwa T; Song WC
J Immunol; 2006 Oct; 177(8):5558-66. PubMed ID: 17015743
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
Barata L; Miwa T; Sato S; Kim D; Mohammed I; Song WC
J Immunol; 2013 Mar; 190(6):2886-95. PubMed ID: 23390291
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg.
Kim DD; Miwa T; Kimura Y; Schwendener RA; van Lookeren Campagne M; Song WC
Blood; 2008 Aug; 112(4):1109-19. PubMed ID: 18524992
[TBL] [Abstract][Full Text] [Related]
6. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
7. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
[TBL] [Abstract][Full Text] [Related]
8. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.
Miwa T; Zhou L; Kimura Y; Kim D; Bhandoola A; Song WC
Blood; 2009 Mar; 113(12):2684-94. PubMed ID: 19136662
[TBL] [Abstract][Full Text] [Related]
9. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
Sun X; Funk CD; Deng C; Sahu A; Lambris JD; Song WC
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):628-33. PubMed ID: 9892684
[TBL] [Abstract][Full Text] [Related]
10. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
[TBL] [Abstract][Full Text] [Related]
11. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
[TBL] [Abstract][Full Text] [Related]
12. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
Pritchard MT; McMullen MR; Stavitsky AB; Cohen JI; Lin F; Edward Medof M; Nagy LE
Gastroenterology; 2007 Mar; 132(3):1117-1126. PubMed ID: 17383432
[TBL] [Abstract][Full Text] [Related]
13. Membrane protein Crry maintains homeostasis of the complement system.
Wu X; Spitzer D; Mao D; Peng SL; Molina H; Atkinson JP
J Immunol; 2008 Aug; 181(4):2732-40. PubMed ID: 18684964
[TBL] [Abstract][Full Text] [Related]
14. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
Li B; Sallee C; Dehoff M; Foley S; Molina H; Holers VM
J Immunol; 1993 Oct; 151(8):4295-305. PubMed ID: 7691944
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
16. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody-mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade.
Auger JL; Haasken S; Binstadt BA
Arthritis Res Ther; 2012 Dec; 14(6):R269. PubMed ID: 23237573
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
Medof ME; Kinoshita T; Nussenzweig V
J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
[TBL] [Abstract][Full Text] [Related]
19. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice.
Fang C; Miwa T; Shen H; Song WC
J Immunol; 2007 Sep; 179(5):3178-86. PubMed ID: 17709533
[TBL] [Abstract][Full Text] [Related]
20. The serum resistance of malaria-infected erythrocytes.
Kawamoto Y; Kojima K; Hitsumoto Y; Okada H; Holers VM; Miyama A
Immunology; 1997 May; 91(1):7-12. PubMed ID: 9203959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
